Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of HPV vaccination with Gardasil® in Switzerland.

BMC infectious diseases - 22 Dec 2017

Jacot-Guillarmod Martine, Pasquier Jérôme, Greub Gilbert, Bongiovanni Massimo, Achtari Chahin, Sahli Roland

Abstract excerpt

BACKGROUND: Gardasil®, a quadrivalent vaccine targeting low-risk (6, 11) and high-risk (16, 18) human papillomaviruses (HPV), has been offered to 11-14 year-old schoolgirls in Switzerland since 2008. To evaluate its success and its potential impact on cervical cancer screening, HPV genotypes were examined in 18-year-old girls five years later (sub-study 1) and in outpatients participating to cervical cancer...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chlamydia Infections
Share to Chlamydia trachomatis
Share to Papillomaviridae

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Papillomavirus Infections

Share to Papillomavirus Vaccines

Share to Switzerland

Share to Uterine Cervical Neoplasms

Share to Vaccination

Source

Open in PubMed Open full text

Identifiers

PMID: 29273004
DOI: 10.1186/s12879-017-2867-x
PMCID: PMC5741926

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of HPV vaccination with Gardasil® in Switzerland.PMID 29273004Read ↗

Human papillomavirus vaccination: the population impactSemantic proximity Read ↗

Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018.Semantic proximity Read ↗

Effectiveness of Human Papillomavirus Vaccination on Prevalence of Vaccine Genotypes in Young Sexually Active Women in France.Semantic proximity Read ↗

Reduction in Vaccine-Type Human Papillomavirus Prevalence Among Women in the United States, 2009-2012.Semantic proximity Read ↗

Postvaccination prevalence of vaccine-Human Papillomavirus (vHPV) genotypes among the target population: A systematic review and meta-analysis.Semantic proximity Read ↗

Human Papillomavirus prevalence and probable first effects of vaccination in 20 to 25 year-old women in Germany: a population-based cross-sectional study via home-based self-sampling.Semantic proximity Read ↗

Risk of cervical HPV infection and prevalence of vaccine-type and other high-risk HPV types among sexually active teens and young women (13-26 years) enrolled in the VALHIDATE study.Semantic proximity Read ↗

Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013.Semantic proximity Read ↗

Human Papillomavirus Epidemiology and Prevention: Is There Still a Gender Gap?Semantic proximity Read ↗

Prevalence of HPV infection among sexually active adolescents and young adults in Brazil: The POP-Brazil Study.Semantic proximity Read ↗

Significantly Reduced Genoprevalence of Vaccine-Type HPV-16/18 Infections among Vaccinated Compared to Non-Vaccinated Young Women 5.5 Years after a Bivalent HPV-16/18 Vaccine (Cervarix®) Pilot Project in Uganda.Semantic proximity Read ↗

Bivalent Vaccine Effectiveness Against Type-Specific HPV Positivity: Evidence for Cross-Protection Against Oncogenic Types Among Dutch STI Clinic Visitors.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.